会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • IMPROVED PURIFICATION OF MULTI-SPECIFIC RECEPTORS
    • 多特异性受体改善AUFREINGUNG
    • EP2477706A2
    • 2012-07-25
    • EP10754335.7
    • 2010-09-16
    • Mipsalus Aps
    • KROGH, Nicolas, OttoGREGORIUS, Klaus
    • B01D15/38
    • A61K31/74B01D15/1807B01D15/3804B01J20/26B01J20/268
    • Disclosed is a method for preparing a composition enriched for receptors (typically molecular impringet polymers, MIPs) that bind an agent, where said receptors each specifically bind at least two discrete sites on said agent, by subjecting a sample of receptors to a first step of affinity purification with the agent where one binding site on the agent is non-accessible for binding to the receptors and subsequently subjecting the purified receptors to at least one further step of affinity purification with the agent where a second binding site on the agent is non-accessible. Also disclosed is a method for treatment, amelioration or prophylaxis of a disease selected from the group consisting of phenylketonuria (PKU, Følling's disease), hyperphenylalaninemia (HPA), alcaptonuria (black urine disease), tyrosinemia, hypertyrosinemia, myasthenia gravis, histidinemia, urocanic aciduria, maple syrup urine disease (MSUD), isovaleric acidemia (isovaleryl-CoA dehydrogenase deficiency), homocystinuria, propionic acidemia, methylmalonic acidemia, and glutaric aciduria Type 1 (GA-I), galactosemia, comprising administering to the gastrointestinal tract of a patient in need thereof an effective amount of a composition of molecular imprinted polymers (MIPs), said composition being capable of binding a symptom provoking agent of said disease.
    • 5. 发明公开
    • IMPROVED PREPARATION OF MOLECULAR IMPRINTED POLYMERS
    • VERBESSERTE HERSTELLUNG VON MOLEKULARGEPRÄGTENPOLYMEREN
    • EP1988993A2
    • 2008-11-12
    • EP07702501.3
    • 2007-02-21
    • Mipsalus Aps
    • KRISTENSEN, Jesper SvenningNIELSEN, Klaus GregoriusKROGH, Nicolas Otto
    • B01J20/26A61K31/74C08J9/02
    • B01J20/26A61K31/74A61K47/58A61K47/593B01J20/268B01J20/3057
    • One aspect is a method for improved preparation of molecular imprinted polymer (MIP) particles, where initial compositions comprising insoluble MIP particles are enriched for those MIP particles that bind a particular target molecule, thus excluding non-binding and weakly binding particles from the final composition. Enrichment is typically accomplished via use of chromatographic methods capable of separating particulate material or by means of agglutination. Another aspect is preparation of improved insoluble MIPs by use of extended micronization of raw MIP particles with a view to expose a large number of binding sites per mass unit of MIP particles. In preferred embodiments the two aspects are combined. The resulting improved MIPs may be used for diagnostic, analytical and therapeutic purposes, notably as orally administered drugs which can bind substances such as cholesterol and bile acids and bile acid salts in the gastrointestinal tract.
    • 一个方面是用于改进分子印迹聚合物(MIP)颗粒的制备的方法,其中包含不溶性MIP颗粒的初始组合被富集用于结合特定靶分子的那些MIP颗粒,从而从最终组合物排除非结合和弱结合的颗粒 。 富集通常通过使用能够分离颗粒材料或通过凝集的色谱方法来完成。 另一方面是通过使用原始MIP颗粒的延长微粉化来制备改进的不溶性MIP,以期暴露每质量单位MIP颗粒的大量结合位点。 在优选实施例中,组合了两个方面。 所得到的改进的MIP可用于诊断,分析和治疗目的,特别是作为可以在胃肠道中结合物质如胆固醇和胆汁酸和胆汁酸盐的口服给药的药物。